Pernix Therapeutics: RBC Global Healthcare Conference (Pernix Therapeutics) - Mar 3, 2016 - Anticipated expiry of patents in US related to multiparticulate modified release compositions on November 1, 2019; Anticipated expiry of patent in US related to abuse deterrent compositions on September 12, 2034; Anticipated expiry of patent in US on critical safety information relating to dosing patients on July 25, 2033
Anticipated patent expiry • Pain
|